This is a synthetic peptide designed for use in combination with anti-Mgll Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Mgll converts monoacylglycerides to free fatty acids and glycerol. Mgll hydrolyzes the endocannabinoid 2-arachidonoylglycerol, and thereby contributes to the regulation of endocannabinoid signaling, nociperception and perception of pain. It regulates the levels of fatty acids that serve as signaling molecules and promote cancer cell migration, invasion and tumor growth.